EA200601456A1 - Способ получения пирролидиноксимов - Google Patents

Способ получения пирролидиноксимов

Info

Publication number
EA200601456A1
EA200601456A1 EA200601456A EA200601456A EA200601456A1 EA 200601456 A1 EA200601456 A1 EA 200601456A1 EA 200601456 A EA200601456 A EA 200601456A EA 200601456 A EA200601456 A EA 200601456A EA 200601456 A1 EA200601456 A1 EA 200601456A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrrolidinoxym
obtaining
formula
dysmenorrhea
prevention
Prior art date
Application number
EA200601456A
Other languages
English (en)
Other versions
EA011026B1 (ru
Inventor
Уилльям Надлер
Дорис Пупович
Original Assignee
Апплайд Рисёрч Системс Арс Холдинг Н. В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Апплайд Рисёрч Системс Арс Холдинг Н. В. filed Critical Апплайд Рисёрч Системс Арс Холдинг Н. В.
Publication of EA200601456A1 publication Critical patent/EA200601456A1/ru
Publication of EA011026B1 publication Critical patent/EA011026B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

В заявке описан новый способ синтеза пирролидиноксимов общей формулы (I). Соединения формулы (I) применимы при лечении и/или предупреждении преждевременных родов, рождения недоношенного ребенка и дисменореи.
EA200601456A 2004-02-26 2005-02-28 Способ получения пирролидиноксимов EA011026B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04100773 2004-02-26
PCT/EP2005/050852 WO2005082848A2 (en) 2004-02-26 2005-02-28 Method for preparing pyrrolidine oximes

Publications (2)

Publication Number Publication Date
EA200601456A1 true EA200601456A1 (ru) 2007-02-27
EA011026B1 EA011026B1 (ru) 2008-12-30

Family

ID=34896105

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601456A EA011026B1 (ru) 2004-02-26 2005-02-28 Способ получения пирролидиноксимов

Country Status (21)

Country Link
US (1) US20070197794A1 (ru)
EP (1) EP1725526B1 (ru)
JP (1) JP2007524702A (ru)
KR (1) KR20060124775A (ru)
CN (1) CN1946686A (ru)
AT (1) ATE380792T1 (ru)
AU (1) AU2005217153A1 (ru)
BR (1) BRPI0508059A (ru)
CA (1) CA2554767A1 (ru)
CY (1) CY1107139T1 (ru)
DE (1) DE602005003803T2 (ru)
DK (1) DK1725526T3 (ru)
EA (1) EA011026B1 (ru)
ES (1) ES2296137T3 (ru)
IL (1) IL177388A0 (ru)
NO (1) NO20064352L (ru)
PL (1) PL1725526T3 (ru)
PT (1) PT1725526E (ru)
SI (1) SI1725526T1 (ru)
UA (1) UA86226C2 (ru)
WO (1) WO2005082848A2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2845850A1 (en) * 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
MX371068B (es) 2014-07-02 2020-01-15 ObsEva SA ((3z,5s)-5-(hidroximetil)-1-[(2'-metil-1,1'-bifenil-4-il)carbonil ]pirrolidin-3-ona o-metiloxima cristalina y métodos de uso de la misma.
WO2021165927A1 (en) * 2020-02-21 2021-08-26 Wockhardt Bio Ag 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329418B1 (en) * 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
BR0109900A (pt) * 2000-03-27 2003-06-03 Applied Research Systems Derivados de pirolidina farmaceuticamente ativos, uso de derivados de pirolidina, composição farmacêutica e processo para preparação de um derivado de pirolidina
IL159219A0 (en) * 2001-06-18 2004-06-01 Applied Research Systems Pyrrolidine oxadiazole derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1946686A (zh) 2007-04-11
EP1725526A2 (en) 2006-11-29
CA2554767A1 (en) 2005-09-09
US20070197794A1 (en) 2007-08-23
WO2005082848A3 (en) 2005-12-01
CY1107139T1 (el) 2012-10-24
DE602005003803T2 (de) 2008-12-24
EP1725526B1 (en) 2007-12-12
EA011026B1 (ru) 2008-12-30
PL1725526T3 (pl) 2008-03-31
WO2005082848A2 (en) 2005-09-09
ATE380792T1 (de) 2007-12-15
ES2296137T3 (es) 2008-04-16
AU2005217153A1 (en) 2005-09-09
NO20064352L (no) 2006-09-26
DK1725526T3 (da) 2008-03-03
PT1725526E (pt) 2007-12-27
KR20060124775A (ko) 2006-12-05
UA86226C2 (en) 2009-04-10
JP2007524702A (ja) 2007-08-30
BRPI0508059A (pt) 2007-07-17
IL177388A0 (en) 2006-12-10
SI1725526T1 (sl) 2008-04-30
DE602005003803D1 (de) 2008-01-24

Similar Documents

Publication Publication Date Title
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
MX2007007845A (es) Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento.
ATE455763T1 (de) Piperidine und verwandte verbindungen zur behandlung von alzheimer-krankheit
NO20053991L (no) Piperazin-2-karboksamidderivater
DE602006010433D1 (de) Für die behandlung von obesitas geeignete tricyclische amidderivate
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
DE602006017980D1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
NO20055741D0 (no) Nye kjemiske forbindelser
NO20073678L (no) Nye fremgangsmater for fremstilling av benzofuran
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
NO20082749L (no) Fremgangsmate for fremstilling av ferri-succinylkasein
TW200635905A (en) Processes for producing 4-aminoquinazolines
NO20073941L (no) Dihydroimidazotiazolderivater
NO20055750L (no) Nye kjemiske forbindelser
DK1670778T3 (da) Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
ATE452134T1 (de) Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete 4-piperazinylpyrimidinverbindungen
CY1107139T1 (el) Μεθοδος παρασκευης πυρρολιδινοξιμων
ATE438617T1 (de) Substituierte cyclohexyl-1,4-diamin-derivate
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
EA200701852A1 (ru) Производные аминокислот

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title